MedTrace Logo

Ipratropium Bromide Spray as Treatment for Sialorrhea in Children

NCT03747536 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-11-21

No results posted yet for this study

Summary

Double-blind, clinical trial investigating the effects of ipratropium spray versus placebo spray in children with sialorrhea

Conditions

  • Sialorrhea

Interventions

DRUG

Ipratropium bromide

ipratropium bromide via metered dose spray (21 micrograms per spray)

OTHER

Placebo

normal saline delivered via metered dose spray

Sponsors & Collaborators

  • London Health Sciences Centre

    lead OTHER

Principal Investigators

  • Julie Strychowsky, MD · London Health Science Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-10-01
Completion
2021-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03747536 on ClinicalTrials.gov